{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:21:23Z","timestamp":1778268083852,"version":"3.51.4"},"reference-count":48,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Provincial Traditional Chinese medicine science and technology project"},{"name":"Zhejiang Provincial Medical and Health Project"},{"name":"\u201cPioneer\u201d and \u201cLeading Goose\u201d R&D Program of Zhejiang"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/07853890.2025.2546701","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:01:21Z","timestamp":1762920081000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and risk factors of abnormal liver function and anti-tuberculosis drug-induced liver injury: a multicenter retrospective study involving 482 chinese pediatric tuberculosis patients"],"prefix":"10.1080","volume":"57","author":[{"given":"Yiqing","family":"Zhou","sequence":"first","affiliation":[{"name":"School of Public Health, Hangzhou Medical College","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis Control and Prevention, Quzhou Center for Disease Control and Prevention","place":["Quzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Chongqing Medical University Affiliated Children\u2019s Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Children\u2019s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Shanghai Public Health Clinical Center, Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Qinghai Province Women and Children\u2019s Hospital","place":["Xining, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pulmonology, The Second Affiliated Hospital and Yuying Children\u2019s Hospital of Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Suzhou No. 5 People\u2019s Hospital","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingshan","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Hangzhou Red Cross Hospital","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Children\u2019s Hospital of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Ningbo No. 2 Hospital","place":["Ningbo, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhui","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hainan Women and Children\u2019s Medical Center","place":["Haikou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangxu","family":"Yang","sequence":"additional","affiliation":[{"name":"Tuberculosis Prevention Institute, Changchun Infectious Disease Hospital","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"Scientific research center, Zhejiang SUKEAN Pharmaceutical Co. LTD","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8997-8619","authenticated-orcid":false,"given":"Fei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"WHO. Global Tuberculosis Report 2024. Geneva: World Health Organization; 2024 [Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024."},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v27i2.3"},{"key":"e_1_3_5_4_1","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update","author":"WHO","year":"2022","unstructured":"WHO. WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update. World Health Organization; 2022."},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2009.02375.x"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-022-04317-7"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-015-1473-1"},{"issue":"12","key":"e_1_3_5_8_1","first-page":"773","article-title":"Retrospective clinical evaluation of anti-tuberculosis drug induced liver injury","volume":"25","author":"Lingwei ML","year":"2016","unstructured":"Lingwei ML, Shengqian L. Retrospective clinical evaluation of anti-tuberculosis drug induced liver injury. Chin J Pharmacoepidemiol. 2016;25(12): 773\u2013776.","journal-title":"Chin J Pharmacoepidemiol"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1344-2"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcma.2017.10.002"},{"issue":"10","key":"e_1_3_5_11_1","first-page":"819","article-title":"Epidemiology of drug-induced liver injury","volume":"20","author":"Shen Tao DZ","year":"2015","unstructured":"Shen Tao DZ, Hui Z. Epidemiology of drug-induced liver injury. Chin Hepatol. 2015;20(10): 819\u2013823.","journal-title":"Chin Hepatol"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157725"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3988"},{"key":"e_1_3_5_14_1","first-page":"81","article-title":"Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity","volume":"132","author":"Singla R","year":"2010","unstructured":"Singla R, Sharma SK, Mohan A, et al. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. Indian J Med Res. 2010;132:81\u201386.","journal-title":"Indian J Med Res"},{"issue":"6","key":"e_1_3_5_15_1","first-page":"468","article-title":"Research of anti-tuberculosis drugs\u2019 hepatotoxicity","volume":"35","author":"Zhong J","year":"2013","unstructured":"Zhong J, Jianjun M, Yun LWJ, et al. Research of anti-tuberculosis drugs\u2019 hepatotoxicity. Chin J Antituberculosis. 2013;35(6): 468\u2013471.","journal-title":"Chin J Antituberculosis"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00753"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-016-0550-0"},{"issue":"2","key":"e_1_3_5_18_1","first-page":"117","article-title":"Anti-tuberculosis therapy induced hepatotoxicity in children","volume":"37","author":"Hotchandani H","year":"2013","unstructured":"Hotchandani H, Moorani N, Kazi Y. Anti-tuberculosis therapy induced hepatotoxicity in children. Pak Pediatr J. 2013;37(2):117\u2013122.","journal-title":"Pak Pediatr J"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31492-9"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002192"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.81874"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2120"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18147574"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.126175"},{"key":"e_1_3_5_25_1","volume-title":"WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents","author":"WHO","year":"2022","unstructured":"WHO. WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents. World Health Organization; 2022."},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001424"},{"issue":"11","key":"e_1_3_5_27_1","first-page":"1069","article-title":"Guidelines for diagnosis and management of drug-induced liver injury caused by anti-tuberculosis drugs (2024 version)","volume":"47","author":"Association TboCM","year":"2024","unstructured":"Association TboCM. Guidelines for diagnosis and management of drug-induced liver injury caused by anti-tuberculosis drugs (2024 version). Chin Soc Tuberculosis Chin Med Assoc. 2024;47(11):1069\u20131090.","journal-title":"Chin Soc Tuberculosis Chin Med Assoc"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.58"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10144-3"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1666ST"},{"key":"e_1_3_5_31_1","unstructured":"Technology Committee on DILI Prevention and Management CMBA. Study Group of Drug-Induced Liver Disease CMAftSoLD. Chinese Guideline for Diagnosis and Management of Drug\u00b7induced Liver Injury (2023 Version); 2023."},{"issue":"1","key":"e_1_3_5_32_1","first-page":"70","article-title":"Analysis of the clinical characteristics of abnormal liver function caused by standard anti-tuberculosis chemotherapy regimens","volume":"36","author":"Yanxiang W","year":"2014","unstructured":"Yanxiang W, Jinwang Z, Zhengyun X, et al. Analysis of the clinical characteristics of abnormal liver function caused by standard anti-tuberculosis chemotherapy regimens. Chin J Antituberculosis. 2014;36(1): 70\u201372.","journal-title":"Chin J Antituberculosis"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2015-133715"},{"issue":"9","key":"e_1_3_5_34_1","first-page":"56","article-title":"Risk factors of drug-induced hepatic injury in tuberculosis patients after anti-tuberculosis therapy","volume":"31","author":"Fang L","year":"2019","unstructured":"Fang L, Shanshan Z, Yongmei L, et al. Risk factors of drug-induced hepatic injury in tuberculosis patients after anti-tuberculosis therapy. Med Pharm J Chin People\u2019s Liber Army. 2019;31(9): 56\u201359.","journal-title":"Med Pharm J Chin People\u2019s Liber Army"},{"issue":"10","key":"e_1_3_5_35_1","first-page":"602","article-title":"Risk factors for anti-tuberculosis drug-induced liver injury in treatment-naive tuberculosis patients","volume":"40","author":"Jing D","year":"2022","unstructured":"Jing D, Yadong W, Caiyan Z. Risk factors for anti-tuberculosis drug-induced liver injury in treatment-naive tuberculosis patients. Chin J Infect Dis. 2022;40(10): 602\u2013606.","journal-title":"Chin J Infect Dis"},{"issue":"11","key":"e_1_3_5_36_1","first-page":"1867","article-title":"Risk factors and strategies of drug-induced liver injury in untreated pulmonary tuberculosis patients","volume":"14","author":"Jiabin M","year":"2016","unstructured":"Jiabin M, Sun Peiying JX. Risk factors and strategies of drug-induced liver injury in untreated pulmonary tuberculosis patients. Chin J General Practice. 2016;14(11): 1867\u20131869.","journal-title":"Chin J General Practice"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2023-0148"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9085-y"},{"issue":"1","key":"e_1_3_5_39_1","first-page":"62","article-title":"Analysis of adverse reactions and risk factors of liver injury caused by anti-tuberculosis drugs","volume":"27","author":"Leina Y","year":"2022","unstructured":"Leina Y, Bin H. Analysis of adverse reactions and risk factors of liver injury caused by anti-tuberculosis drugs. J Clin Pulmonary Med. 2022;27(1): 62\u201367.","journal-title":"J Clin Pulmonary Med"},{"issue":"4","key":"e_1_3_5_40_1","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais BJ","year":"2004","unstructured":"Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8(4):392\u2013402.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30047-3"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00133-20"},{"issue":"01","key":"e_1_3_5_43_1","first-page":"000","article-title":"Feasibility analysis of retreated pulmonary tuberculosis patients receiving streptomycin or levofloxacin regimen","author":"Wencheng J.","year":"2020","unstructured":"Wencheng J. Feasibility analysis of retreated pulmonary tuberculosis patients receiving streptomycin or levofloxacin regimen. J Med Inform. 2020;(S01):000.","journal-title":"J Med Inform"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05207.x"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.920350"},{"issue":"5","key":"e_1_3_5_46_1","first-page":"36","article-title":"Analysis of risk factors for liver injury caused by anti-tuberculosis drugs based on an artificial neural network model","volume":"33","author":"Fumin HJ.","year":"2024","unstructured":"Fumin HJ. Analysis of risk factors for liver injury caused by anti-tuberculosis drugs based on an artificial neural network model. Chin J Convalesc Med. 2024;33(5): 36\u201339.","journal-title":"Chin J Convalesc Med"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30006-6"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12050790"},{"issue":"1","key":"e_1_3_5_49_1","first-page":"45","article-title":"Analysis of status and influencing factors associated with anti-tuberculosis drug-related liver injury in children","volume":"45","author":"Chen F","year":"2023","unstructured":"Chen F, Zhang X, Zhou H, et al. Analysis of status and influencing factors associated with anti-tuberculosis drug-related liver injury in children. Chin J Antituberculosis. 2023;45(1): 45\u201351.","journal-title":"Chin J Antituberculosis"}],"container-title":["Annals of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07853890.2025.2546701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:01:27Z","timestamp":1762920087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07853890.2025.2546701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/07853890.2025.2546701"],"URL":"https:\/\/doi.org\/10.1080\/07853890.2025.2546701","relation":{},"ISSN":["0785-3890","1365-2060"],"issn-type":[{"value":"0785-3890","type":"print"},{"value":"1365-2060","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2546701"}}